Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Intercept Pharmaceuticals Inc. logo

Intercept Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

19.00
 
USD
  
0.00
  
(0.00%)
Optionable: Yes  Market Cap: 795 M  90-day average vol: 0

Previous close: 19.0  Open: 19.0  Bid:   Ask:
52 week range    
8.82   
   20.95
Peers   
LLY / 
BMY / 
GILD / 
ENZN / 
Last updated: Thursday 29th February 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BMY

0.0332145 B-27.366.19

ENZN

0 B-10.30.3736

GILD

0.044486 B11.763.76

LLY

0.0161238 B37.4243.55

MNOV

0 B-10.82.42
Financials

ICPT Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AllowancesForConstruction5 M
Basic EPS from continuing operations-8.34-2.87-5.17
Basic EPS total-1.63-8.34-2.876.56
Basic weighted shares outstanding18 M21 M24 M25 M25 M28 M32 M33 M32 M34 M
BasicDiscontinuousOperations11.72
Cost of sales-41 M-115 M-232 M-1 M3 M4 M5 M1 M-984000.0
Depreciation-2 M-4 M-5 M-5 M4 M3 M3 M-592000.0
Depreciation unreconciled-106000.0-443000.0
DepreciationAndAmortization-106000.0-443000.0-2 M-4 M-5 M-5 M4 M3 M3 M-592000.0
Diluted EPS total-3.76-13.63-9.56-16.74-14.38-10.86-10.89-8.34-2.876.56
Diluted normalized net income/share-10.86-10.89-2.87-5.17
Diluted weighted shares outstanding18 M21 M24 M25 M25 M28 M32 M33 M32 M34 M
DilutedDiscontinuousOperations11.72
GainOnSaleOfSecurity123000.0299000.02 M737000.0878000.0
GeneralAndAdministrativeExpense13 M35 M-4 M-5 M-9 M-6 M317 M332 M177 M
Gross operating profit2 M2 M3 M25 M130 M177 M252 M307 M260 M285 M
Income before tax-68 M-283 M-226 M-413 M-360 M-309 M-345 M-246 M-137 M-175 M
Income restructuring and M&A-5 M15 M
Income taxes-36000.0-194000.0127000.0825000.0539000.0195000.0-2 M225000.0-5 M
Interest income-28 M
InterestExpenseNonOperating14 M29 M31 M41 M48 M54 M21 M
MiscOtherSpecialCharges-28 M-171 M3 M4 M5 M7 M9 M4 M18 M-85 M
Net income from total operations-68 M-283 M-226 M-413 M-360 M-309 M-345 M-275 M-91 M-175 M
NetIncomeCommonStockholders-68 M-283 M-226 M-413 M-360 M-309 M-345 M-246 M-137 M-175 M
NetIncomeContinuousOperations-68 M-283 M-226 M-413 M-360 M-309 M-345 M-275 M-91 M-175 M
NetIncomeDiscontinuousOperations45 M397 M
NetNonOperatingInterestIncomeExpense-28 M-14 M-29 M-31 M-41 M-48 M-54 M-21 M
NonRecurringOperationExpense1 M
Normalized income-107 M
Operating income-39 M-112 M-229 M-403 M-336 M-285 M-312 M-231 M-100 M-68 M
Operating income before depreciation (EBITDA)-66 M-279 M-218 M-389 M-325 M-273 M-298 M-192 M-77 M-150 M
OperatingExpense41 M-115 M-232 M-427 M-467 M463 M560 M524 M360 M353 M
Other income net28 M171 M-3 M-4 M-5 M-7 M-9 M908000.0-18 M85 M
OtherGainLossFromDispositionOfDiscontinuedOperations45 M
OtherGandA13 M35 M-4 M-5 M-9 M-6 M317 M332 M177 M
OtherOperatingExpenses-100375.0-776000.0-3 M8 M12 M9 M4000.0
OtherWriteOff23000.038000.0
RentAndLandingFees13 M35 M-4 M-5 M-9 M-6 M
Research & development expense28 M80 M113 M154 M191 M207 M243 M191 M183 M177 M
ResearchExpense28 M80 M113 M154 M191 M207 M243 M191 M183 M177 M
RestructringAndMnAIncome-5 M15 M
Revenue per share21 M3 M3 M-3 M
SalariesAndWages-9 M-20 M-34 M-46 M-57 M-50 M56 M61 M28 M-22 M
Selling Gen & administrative expense13 M35 M119 M274 M274 M255 M317 M332 M177 M176 M
SellingAndMarketingExpense119 M274 M274 M255 M317 M176 M
SellingExpense119 M274 M274 M255 M317 M176 M
Special income/charges5 M-15 M-1 M
Total Income available for interest expense (EBIT)-68 M-283 M-226 M-399 M-331 M-279 M-304 M-198 M-83 M-153 M
Total common shares outstanding20 M23 M24 M25 M25 M30 M33 M33 M30 M42 M
Total net income-68 M-283 M-226 M-413 M-360 M-309 M-345 M-275 M-91 M-175 M
Total ordinary shares42 M42 M42 M42 M42 M42 M42 M42 M42 M42 M
Total revenues2 M2 M3 M25 M131 M180 M252 M313 M261 M286 M
TotalExpenses-100375.0-230 M232 M-427 M-468 M465 M560 M529 M361 M352 M
TotalRevenue2 M2 M3 M18 M131 M180 M252 M313 M261 M286 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University